Pathogens (Jan 2023)

Hepatitis C Virus Micro-Elimination Plan in Southern Italy: The “HCV ICEberg” Project

  • Carmine Coppola,
  • Loreta A. Kondili,
  • Laura Staiano,
  • Simona Cammarota,
  • Anna Citarella,
  • Mirko Pio Aloisio,
  • Angelo Annunziata,
  • Francesca Futura Bernardi,
  • Aldo D’Avino,
  • Michele D’Orazio,
  • Marianna Fogliasecca,
  • Mario Fusco,
  • Federica Pisano,
  • Adriano Vercellone,
  • Elvira Bianco,
  • Ugo Trama

DOI
https://doi.org/10.3390/pathogens12020195
Journal volume & issue
Vol. 12, no. 2
p. 195

Abstract

Read online

This study evaluates the feasibility of a local action program for HCV micro-elimination in highly endemic areas. Retrospective analysis: administrative and laboratory data (Local Health Unit, southern Italy) were integrated to quantize the anti-HCV-positive subjects not RNA tested and untreated HCV-infected subjects (2018–2022). Prospective analysis: all subjects admitted to a division of the LHU largest hospital (2021–2022) were tested for HCV, with linkage of active-infected patients to care. Overall, 49287 subjects were HCV-Ab tested: 1071 (2.2%) resulted positive without information for an HCV RNA test and 230 (0.5%) had an active infection not yet cured. Among 856 admitted subjects, 54 (6.3%) were HCV-Ab+ and 27 (3.0%) HCV RNA+. Of HCV-infected patients, 22.2% had advanced liver disease, highlighting the need for earlier diagnosis; 27.7% were unaware of HCV infection; and 20.4% were previously aware but never referred to a clinical center. Of these, 26% died and 74% received treatment. Our study emphasizes the value of an active HCV hospital case-finding program to enhance diagnosis in patients with several comorbidities and to easily link them to care. Our data strongly suggest extending this program to all hospital wards/access as a standard of care, particularly in highly endemic areas, to help HCV disease control and take steps in achieving the elimination goals.

Keywords